Depression Care360

Anti-inflammatory treatments significantly reduced anhedonia and depressive symptom severity in patients with depression and elevated inflammation.

A new systematic review and network meta-analysis has found that slow antidepressant tapering combined with psychological support is as effective as continuation therapy in preventing relapse in adults with...

A retrospective analysis of wellness evaluations from pharmacy residents across Kaleida Health assessed trends in stress, well-being, burnout, grit, and imposter phenomenon to help preceptors and program...

A longitudinal analysis found that experiences of discrimination were associated with a higher risk of major depressive episodes (MDEs) among higher education students.

Ketogenic diets (KDs) were associated with modest improvements in depressive symptoms in a recent systematic review and meta-analysis.

Serial ketamine infusions failed to outperform a psychoactive placebo as an adjunctive therapy to usual inpatient care for depression.

Ammoxetine significantly reduced depressive symptoms and was well-tolerated in adult patients with MDD.

Add-on simvastatin did not offer additional antidepressive effects in patients with comorbid MDD and obesity.

Esketamine monotherapy significantly reduced depressive symptoms in adult patients with treatment-resistant depression (TRD) compared to placebo, according to randomized clinical trial results.

Initial data from the core stage of a phase 2b clinical trial showed that an intranasal formulation of mebufotenin benzoate, BPL-003, significantly reduced depressive symptoms in patients with...